NASDAQ : BBTX

Bambusa Therapeutics, Inc. — Key statistics

Healthcare · Biotechnology · United States

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

Measure	Value
Market Cap	787.06M
Enterprise Value	715.59M

Dates

Measure	Value
Earnings Date	n/a
Ex-Dividend Date	n/a

Shares

Measure	Value
Current Share Class	50.94M
Shares Outstanding	50.94M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.09%
Owned by Institutions (%)	9.25%
Float	23.09M

Ratios

Measure	Value
PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	12.14
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Evratios

Measure	Value
EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financialposition

Measure	Value
Current Ratio	6.16
Quick Ratio	5.95
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financialefficiency

Measure	Value
Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-75.12%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Measure	Value
Income Tax	2.58M
Effective Tax Rate	n/a

Stockprice

Measure	Value
Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	732,827

Shortselling

Measure	Value
Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Incomestatement

Measure	Value
Revenue	n/a
Gross Profit	n/a
Operating Income	-49.03M
Pretax Income	-46.12M
Net Income	-48.70M
EBITDA	n/a
EBIT	-49.03M
Earnings Per Share (EPS)	-$6.08

Balancesheet

Measure	Value
Cash & Cash Equivalents	71.48M
Total Debt	n/a
Net Cash	71.48M
Net Cash Per Share	$1.40
Equity (Book Value)	65.27M
Book Value Per Share	-8.86
Working Capital	63.08M

Cashflow

Measure	Value
Operating Cash Flow	-40.90M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Measure	Value
Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends

Measure	Value
Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-39.35%
FCF Yield	n/a

Analystforecasts

Measure	Value
Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stocksplits

Measure	Value
Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Measure	Value
Altman Z-Score	n/a
Piotroski F-Score	n/a

Fairvalue

Measure	Value
Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a